Skip to content

A prospective cohort study of different thresholds and intensities to correct acute hypofibrinogenemia in patients with traumatic brain injury

A prospective cohort study of different thresholds and intensities to correct acute hypofibrinogenemia in patients with traumatic brain injury

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035611
Enrollment
Unknown
Registered
2020-08-15
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

traumatic brain injury

Interventions

Group 1:intensive fibrinogen correction
Group 2:conventional fibrinogen correction

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 70 years; 2. Clear history of head trauma and traumatic intracranial lesions (acute epidural hematoma, acute subdural hematoma, brain contusion, intracerebral hematoma, diffuse axonal injury, brain stem injury, etc.) confirmed by head CT; 3. The patient was admitted to the hospital or emergency department within 12 hours after the onset of the disease, and the head CT was completed within 1 hour to confirm the presence of traumatic intracranial lesions; 4. The fibrinogen level was less than 2.0 L/h after admission.

Exclusion criteria

Exclusion criteria: 1. Patients with GCS score of 3 and bilateral fixed pupil; 2. Patients with previous brain diseases with neurological deficits or disturbance of consciousness; 3. Patients with life expectancy less than 3 days after onset of disease; 4. Pregnancy, childbirth or lactation within 30 days; 5. The patient had severe liver dysfunction before the onset of the disease; 6. The patients had decreased fibrinogen level or dysfunction before the onset of the disease; 7. The patient had congenital or acquired thrombocytopenia before onset; 8. The patients only with scalp hematoma and skull fracture confirmed by head CT; 9. The patient had no history of long-term or recent anticoagulant and antiplatelet drugs before onset.

Design outcomes

Primary

MeasureTime frame
GOSE at 180 days after injury;

Secondary

MeasureTime frame
Mortality at 180 days after injury;Rate of progressive intracranial hemorrhage;

Countries

China

Contacts

Public ContactQiang Yuan

Huashan Hospital, Fudan University

297260090@qq.com+86 18930174565

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026